Craft

MiCo BioMed

Revenue

₩4.1 B

FY, 2019

MiCo BioMed Summary

Company Summary

Overview
MiCo BioMed is a provider of diagnostic labchips, reagents, and diagnostic equipment based on Lab-on-a-Chip technology. It operates through three businesses: Molecular Diagnosis, Biochemistry Diagnosis, and Immunity Diagnosis. MiCo BioMed develops and sells medical kits, ultra-fast labchip real-time polymerase chain reaction equipment, ultrafast real-time polymerase chain reaction labchips, and other products.
Type
Public
Status
Active
Founded
2009
HQ
Seongnam-si, KR | view all locations
Website
http://www.micobiomed.com/en/
Cybersecurity rating
Sectors

Key People

  • Sung woo Kim

    Sung woo Kim, CEO

    Operating MetricsView all

    Patents

    124

    H1, 2020

    Divisions

    8

    H1, 2020

    LocationsView all

    4 locations detected

    • Seongnam-si, Gyeonggi-do HQ

      Korea (Republic of)

      3rd and 4th Floor , 54 Changeop-ro, Sujeong-gu

    • Blue Ash, OH

      United States

      10999 Reed Hartman Hwy

    • Vinhedo, SP

      Brazil

      Rua Alziro Cicchetto, 185 - Distrito Industrial Benedito Storani

    • Anseong, Gyeonggi-do

      Korea (Republic of)

      116, Gongdan 1-ro

    MiCo BioMed Financials

    Summary Financials

    Revenue (H1, 2020)
    ₩21.7B
    Gross profit (H1, 2020)
    ₩10.3B
    Net income (H1, 2020)
    (₩15.3B)
    Cash (H1, 2020)
    ₩2.9B
    EBIT (H1, 2020)
    ₩2.4B

    Footer menu